Peroxotitanates for biodelivery of metals.


Metal-based drugs are largely undeveloped in pharmacology. One limiting factor is the systemic toxicity of metal-based compounds. A solid-phase, sequestratable delivery agent for local delivery of metals could reduce systemic toxicity, facilitating new drug development in this nascent area. Amorphous peroxotitanates (APT) are ion-exchange materials with… (More)
DOI: 10.1002/jbm.b.31402


Cite this paper

@article{Wataha2009PeroxotitanatesFB, title={Peroxotitanates for biodelivery of metals.}, author={John C Wataha and David T Hobbs and Petra E Lockwood and Ryan R Davis and Mark C Elvington and Jill B. Lewis and Regina L W Messer}, journal={Journal of biomedical materials research. Part B, Applied biomaterials}, year={2009}, volume={91 2}, pages={489-96} }